Articles
12258 items
Antibacterial company Entasis proposes NASDAQ IPO
Entasis Therapeutics Inc. (Waltham, Mass.) proposed on Friday to raise $86.3 million in an IPO on NASDAQ underwritten by Credit Suisse, BMO Capital Markets, SunTrust Robinson Humphrey and Wedbush PacGrow.
In September, the antibacterial company raised...
Harbin Gloria selling stake in biotech unit
Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437) said Friday it plans to sell a 51% stake in biotech subsidiary Guangzhou Gloria Biotechnology Co. Ltd. (Guangzhou, China) to 6 Dimensions Capital, Boyu Capital and two other investors.
The...
Blackstone investing $400M in Chinese company HEC
YiChang HEC Changjiang Pharmaceutical Co. Ltd. (HKSE:1558) said it will sell $400 million in convertible bonds to Blackstone Group, according to a filing on Hong Kong Exchanges and Clearing Ltd. (HKEX).
The bonds will bear 3%...
Third Rock names Kafka venture partner
Third Rock Ventures named Steve Kafka venture partner. He was president and COO at cancer genomics company Foundation Medicine Inc., which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Prior to that, he was COO and CFO at stapled...
Loncar's China biopharma fund to list on NASDAQ Wednesday
The Loncar China BioPharma ETF (NASDAQ:CHNA) is scheduled to begin trading on NASDAQ on Wednesday.
The ETF bundles the companies of the Loncar China BioPharma Index (LCHINA) under one security that trades in the U.S. Brad...
Crossover investors join Orchard's syndicate in $150M series C
Gene therapy company Orchard Therapeutics Ltd. (London, U.K.) raised $150 million in a series C round led by Deerfield Management. Also participating were new investors RA Capital, Venrock, Foresite Capital, Perceptive Advisors, Cormorant Asset Management,...
MD Anderson launches neuroscience newco with $31M series A
The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners (Seattle, Wash.) have co-founded Magnolia Neurosciences Corp. (New York, N.Y.), which launched Monday with a $31 million series A round.
Participating in the...
RegenxBio raises $175.5M follow-on
RegenxBio Inc. (NASDAQ:RGNX) raised $175.5 million through the sale of 2.7 million shares at $65 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Raymond James.
On Wednesday, the company disclosed a treatment-related...
NeoGenomics raises $125M follow-on
NeoGenomics Inc. (NASDAQ:NEO) raised $125 million through the sale of 9.8 million shares at $12.75 in an follow-on underwritten by William Blair, Leerink Partners, Craig-Hallum, Stephens, First Analysis Securities, Janney Montgomery Scott and Benchmark Co....
Artios raises £65M series B
Artios Pharma Ltd. (Cambridge, U.K.) raised £65 million ($84.3 million) in an oversubscribed, tranched series B round led by new investors Andera Partners and LSP. Fellow new investors Pfizer Ventures and Novartis Venture Fund also...
